Close

Dr Hannah Whiteman

BSc MSc PhD

Professional Services
- Head of Strategic Research

Room
G40a

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Tel.
020 7927 2568

 

Hannah joined the School in June 2012 as Strategic Research Co-ordinator. Before joining the School she worked at Cancer Research UK as a Research Funding Manager, and prior to this as a postdoctoral researcher at Barts and The London School of Medicine and Dentistry.

 

Affiliations

Executive Office
Professional Support Services

Selected Publications

AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D.
Dumartin L; Whiteman HJ; Weeks ME; Hariharan D; Dmitrovic B; Iacobuzio-Donahue CA; Brentnall TA; Bronner MP; Feakins RM; Timms JF
2011
Cancer research
Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma.
Weeks ME; Hariharan D; Petronijevic L; Radon TP; Whiteman HJ; Kocher HM; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
2008
Proteomics Clinical applications
Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets.
Chelala C; Hahn SA; Whiteman HJ; Barry S; Hariharan D; Radon TP; Lemoine NR; Crnogorac-Jurcevic T
2007
BMC genomics
The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
Whiteman HJ; Weeks ME; Dowen SE; Barry S; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
2007
Cancer research
RUNX expression and function in human B cells.
Whiteman HJ; Farrell PJ
2006
Critical reviews in eukaryotic gene expression
Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
Spender LC; Whiteman HJ; Karstegl CE; Farrell PJ
2005
Oncogene
See more Publications